- Home
- IPHA vs DSP Comparison
IPHA vs DSP Comparison
Compare IPHA & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- DSP
- Stock Information
- Founded
- IPHA 1999
- DSP 1999
- Country
- IPHA France
- DSP United States
- Employees
- IPHA N/A
- DSP N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- DSP EDP Services
- Sector
- IPHA Health Care
- DSP Technology
- Exchange
- IPHA Nasdaq
- DSP Nasdaq
- Market Cap
- IPHA 160.1M
- DSP 220.3M
- IPO Year
- IPHA 2019
- DSP 2021
- Fundamental
- Price
- IPHA N/A
- DSP $13.78
- Analyst Decision
- IPHA Strong Buy
- DSP Strong Buy
- Analyst Count
- IPHA 1
- DSP 8
- Target Price
- IPHA $11.00
- DSP $21.75
- AVG Volume (30 Days)
- IPHA 11.7K
- DSP 242.9K
- Earning Date
- IPHA 03-27-2025
- DSP 08-11-2025
- Dividend Yield
- IPHA N/A
- DSP N/A
- EPS Growth
- IPHA N/A
- DSP N/A
- EPS
- IPHA N/A
- DSP 0.13
- Revenue
- IPHA $20,831,349.00
- DSP $306,484,000.00
- Revenue This Year
- IPHA $209.83
- DSP $18.36
- Revenue Next Year
- IPHA $83.15
- DSP $15.95
- P/E Ratio
- IPHA N/A
- DSP $106.28
- Revenue Growth
- IPHA N/A
- DSP 30.64
- 52 Week Low
- IPHA $1.29
- DSP $8.70
- 52 Week High
- IPHA $3.51
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- IPHA 39.24
- DSP 53.27
- Support Level
- IPHA $1.71
- DSP $12.79
- Resistance Level
- IPHA $1.90
- DSP $13.72
- Average True Range (ATR)
- IPHA 0.09
- DSP 0.61
- MACD
- IPHA -0.00
- DSP 0.08
- Stochastic Oscillator
- IPHA 40.74
- DSP 95.48
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.